Novartis Ag (NVS) EBT Margin (2009 - 2026)
Novartis Ag's EBT Margin was 29.63% in Q2 2026, down 2.61 percentage points from 32.24% a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) EBT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novartis Ag's EBT Margin was 29.62% through Jun 30, 2026, down 1.01 percentage points year-over-year; for FY2025, it came in at 29.99%, up 2.88 percentage points from FY2024.
- EBT Margin has now increased for three consecutive years, with a five-year change of +9.69 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was 27.11% in FY2024 (+7.03 pp), 20.08% in FY2023 (+3.07 pp), 17.00% in FY2022 (-40.33 pp) and 57.34% in FY2021 (+37.04 pp).
- The Q2 2026 figure marks the lowest quarterly EBT Margin since Q2 2023.
- The best year-over-year quarter for EBT Margin over five years was Q4 2021 (a gain of 108.10 percentage points); the worst was Q4 2022 (a drop of 114.42 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | -4.34% |
| 10 | Vertex Pharmaceuticals | 131.60 Bn | 103.61 Bn | 2.84 Bn | 41.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.63% |
| Mar 31, 2026 | 29.28% |
| Dec 31, 2025 | 24.13% |
| Sep 30, 2025 | 30.17% |
| Jun 30, 2025 | 32.24% |
| Mar 31, 2025 | 33.30% |
| Dec 31, 2024 | 24.98% |
| Sep 30, 2024 | 26.40% |
| Jun 30, 2024 | 30.70% |
| Mar 31, 2024 | 26.45% |
| Dec 31, 2023 | 20.81% |
| Sep 30, 2023 | 13.17% |
| Jun 30, 2023 | 23.38% |
| Mar 31, 2023 | 23.34% |
| Dec 31, 2022 | 14.84% |
| Sep 30, 2022 | 15.13% |
| Jun 30, 2022 | 15.98% |
| Mar 31, 2022 | 21.30% |
| Dec 31, 2021 | 128.14% |
| Sep 30, 2021 | 24.79% |
API Access
Novartis Ag EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();